The announcement of a virtual event to showcase the NanoKnife™ System suggests AngioDynamics is focusing on innovation and expanding its product offerings. This could positively influence investor sentiment, especially if the product is well-received. The timing after the Q2 results may also provide a comprehensive view of the company's performance and future prospects.